# A Study to Explore the Effect of Sepranolone in Tourette Syndrome

> **NCT05434546** · PHASE2 · COMPLETED · sponsor: **Asarina Pharma** · enrollment: 26 (actual)

## Conditions studied

- Tourette Syndrome
- Tourette Syndrome in Adolescence

## Interventions

- **DRUG:** Sepranolone

## Key facts

- **NCT ID:** NCT05434546
- **Lead sponsor:** Asarina Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-02-16
- **Primary completion:** 2023-02-01
- **Final completion:** 2023-02-01
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2023-06-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05434546

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05434546, "A Study to Explore the Effect of Sepranolone in Tourette Syndrome". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05434546. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*